ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00294437
Recruitment Status : Terminated (underfunding)
First Posted : February 22, 2006
Last Update Posted : May 1, 2012
Information provided by:
Central European Cooperative Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2003
  Actual Study Completion Date : November 2007